26090-29-9 Usage
Description
N-Diethylaminoethyl-p-[2-(-n-octyloxy)-benzoyl]aminobenzoate, a derivative of Otilonium Bromide, is a light yellow solid with unique chemical properties. It is characterized by its distinct molecular structure, which contributes to its potential applications across various industries.
Uses
Used in Pharmaceutical Industry:
N-Diethylaminoethyl-p-[2-(-n-octyloxy)-benzoyl]aminobenzoate is used as an active pharmaceutical ingredient for the development of medications targeting specific medical conditions. Its unique chemical structure allows it to interact with biological systems in ways that can be harnessed for therapeutic purposes.
Used in Chemical Research:
In the field of chemical research, N-Diethylaminoethyl-p-[2-(-n-octyloxy)-benzoyl]aminobenzoate serves as a valuable compound for studying the properties and behavior of organic molecules. Its light yellow solid form and derivative nature make it an interesting subject for scientific inquiry and potential innovation.
Used in Material Science:
N-Diethylaminoethyl-p-[2-(-n-octyloxy)-benzoyl]aminobenzoate can be utilized in material science for the development of new materials with specific properties. Its light yellow solid form and chemical composition may contribute to the creation of materials with unique characteristics for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 26090-29-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,0,9 and 0 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 26090-29:
(7*2)+(6*6)+(5*0)+(4*9)+(3*0)+(2*2)+(1*9)=99
99 % 10 = 9
So 26090-29-9 is a valid CAS Registry Number.
26090-29-9Relevant articles and documents
ANTIBIOTIC AMMONIUM COMPOUNDS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS
-
Paragraph 0119, (2020/08/22)
The present disclosure provides ammonium compounds, e.g., compounds according to Formula I as set forth herein, which are useful as antimicrobial agents. Methods for the treatment of bacterial infections and associated conditions, e.g., gastrointestinal conditions, are also described, as well as methods for altering the microbiome of subjects such as humans.
